US Stock MarketDetailed Quotes

REPL Replimune

Watchlist
  • 6.450
  • -0.520-7.46%
Close Apr 19 16:00 ET
  • 6.530
  • +0.080+1.24%
Post 19:57 ET
395.95MMarket Cap-2041P/E (TTM)

About Replimune Company

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Company Profile

SymbolREPL
Company NameReplimune
Listing DateJul 20, 2018
Issue Price15.00
Founded2017
CEOMr. Sushil Patel, PhD
MarketNASDAQ
Employees284
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address500 Unicorn Park Drive,Suite 303,3rd Floor
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-222-9600
Websitehttp://www.replimune.com

Company Executives

  • Name
  • Position
  • Salary
  • Sushil Patel, PhD
  • Director and Chief Executive Officer
  • 2.60M
  • Dr. Colin Love, PhD
  • Chief Operating Officer
  • --
  • Christopher Sarchi
  • Chief Commercial Officer
  • --
  • Paul Bullock
  • Chief Manufacturing Officer
  • --
  • Andrew Schwendenman
  • Chief Accounting Officer
  • --
  • Dr. Konstantinos Xynos, M.D.
  • Chief Medical Officer
  • --
  • Emily Hill
  • Chief Financial Officer
  • --
  • Philip Astley-Sparke
  • Executive Chairman of the Board
  • 3.65M
  • Dr. Robert Coffin, PhD
  • Director and Chief Scientist
  • 2.93M
  • Veleka Peeples-Dyer
  • Independent Director
  • --
  • Paolo Pucci
  • Independent Director
  • 251.96K
  • Dr. Kapil Dhingra, M.B.B.S.
  • Independent Director
  • 252.96K
  • Dr. Hyam I. Levitsky,M.D.
  • Independent Director
  • 251.96K
  • Christy J. Oliger
  • Independent Director
  • 248.46K
  • Joseph P. Slattery, C.P.A.
  • Independent Director
  • 255.96K
  • Dieter Weinand
  • Lead Independent Director
  • 371.44K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg